Valuation: Orthofix International NV

Market Cap 402M 351M 323M 301M 571M 38.26B 579M 3.88B 1.51B 18.8B 1.51B 1.48B 64.8B P/E 2026 *
-8.18x
P/E 2027 * -9.84x
Enterprise Value 402M 351M 323M 301M 571M 38.26B 579M 3.88B 1.51B 18.8B 1.51B 1.48B 64.8B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.46x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 54 08/06/2020
Director/Board Member 65 14/12/2023
Director/Board Member 64 05/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 402M
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.73%+4.67%+6.30%+0.29% 59.87B
Weighted average by Cap. +3.31%+3.80%-3.84%+1.05%

Financials

2026 *2027 *
Net sales 841M 735M 676M 630M 1.19B 80.1B 1.21B 8.11B 3.15B 39.38B 3.16B 3.09B 136B 881M 771M 708M 660M 1.25B 83.93B 1.27B 8.5B 3.31B 41.26B 3.31B 3.24B 142B
Net income -47.49M -41.51M -38.15M -35.56M -67.45M -4.52B -68.47M -458M -178M -2.22B -178M -174M -7.66B -40.38M -35.3M -32.44M -30.24M -57.35M -3.84B -58.22M -389M -151M -1.89B -152M -148M -6.51B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-